Iranian knowledge-based company develops nano kit for early detection of stomach cancer
An Iranian knowledge-based company has developed a rapid nano-diagnostic kit capable of detecting Helicobacter pylori—the leading preventable cause of stomach cancer—with high accuracy and without the need for invasive procedures.
According to Iran’s Nanotechnology Development Headquarters, the kit was developed by Zist Tashkhis Sanjeh and is based on Lateral Flow Assay (LFA) technology.
The newly developed kit offers a faster and more accessible tool for early diagnosis and screening, the report said.
The product enables the rapid, simple, and cost-effective detection of H. pylori infections, which are closely linked to gastric ulcers, duodenal ulcers, and stomach cancer, it added.
Helicobacter pylori is among the most widespread bacterial infections worldwide, with health experts estimating that more than half of the global population encounters the bacterium during their lifetime.
The infection remains one of the most significant risk factors for chronic gastric diseases and certain gastrointestinal cancers.
The newly developed kit identifies H. pylori surface antigens in stool samples using antibody-based detection technology.
⚕️ Iran’s homegrown AlphaZa cancer radiopharmaceutical nears market launch, says nuclear chief#IranFirsthttps://t.co/Y4cGjMpHI4
— Iran First (@IranFirst_PTV) June 16, 2026
Compared with conventional diagnostic methods, it provides faster results, lower costs, and greater convenience while eliminating the need for sophisticated laboratory equipment and invasive testing procedures.
The product can be used in medical laboratories, hospitals, healthcare centers, gastroenterology clinics, pharmacies, and even home settings for preliminary screening.
Its broad accessibility is expected to facilitate earlier diagnosis and improve access to diagnostic services.
Medical specialists emphasize that timely detection of H. pylori is critical because the infection can often be successfully treated with medication, helping prevent disease progression and reducing the risk of serious complications, including stomach cancer.
In addition to this product, Zist Tashkhis Sanjeh manufactures a range of rapid diagnostic kits based on Lateral Flow Assay technology.
Such tools are particularly valuable in emergencies, underserved areas, and healthcare facilities with limited access to advanced laboratory infrastructure.
Experts believe that expanding domestic production of advanced diagnostic technologies can reduce reliance on imported medical products, strengthen national screening programs, improve patient access to healthcare services, and help lower healthcare costs while enhancing public health outcomes.
Iran secures place among world’s top five regenerative medicine powers
Iran’s deep brain stimulation technology for Parkinson’s treatment to enter human trials by 2027
Iran’s homegrown AlphaZa cancer radiopharmaceutical nears market launch: Nuclear chief
Israeli strike on Gaza home kills father and two young daughters in their sleep
Israeli strikes kill over a dozen in Lebanon's Natabieh
Official: 480 enemy-linked individuals arrested in West Azerbaijan during US-Israeli war
VIDEO | Outrage over prices, profiling and persecution at US World Cup matches
Tehran condemns US threat to use Iranian assets to compensate regional allies
Iranian knowledge-based company develops nano kit for early detection of stomach cancer
German Chancellor blocks efforts to sanction Israel
Hezbollah will respond to any Israeli aggression; Iran committed to backing Lebanon: MP
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
